Overview

A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and effectiveness of three doses of asoprisnil, compared to placebo, in the treatment of women with endometriosis.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott